1. Guidance on the Clinical Management of Electronic Cigarette or Vaping-Associated Lung Injury
- Author
-
Madhusmita Behera, Victoria Hyland, Shawn J. Rice, Suresh S. Ramalingam, Paul A. Bunn, and Chandra P. Belani
- Subjects
Male ,0301 basic medicine ,Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Lung Neoplasms ,Adolescent ,Review Article ,Acute respiratory distress ,Electronic Nicotine Delivery Systems ,Lung injury ,Patient care ,law.invention ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,law ,medicine ,Humans ,Young adult ,Pandemics ,SARS-CoV-2 ,business.industry ,Vaping ,Public health ,EVALI ,COVID-19 ,Lung Injury ,United States ,Clinical Practice ,E-cigarettes ,030104 developmental biology ,Oncology ,Respiratory injury ,030220 oncology & carcinogenesis ,Emergency medicine ,Female ,business ,Electronic cigarette - Abstract
In the summer of 2019, there was a rise in clusters of adolescents and young adults in the United States reporting to emergency departments with acute respiratory distress related to use of e-cigarette (electronic cigarette) or vaping. The number of patients with e-cigarette or vaping-associated lung injury continued to rise through the summer before peaking in September 2019. Through the efforts of state and federal public health agencies, officials were able to define the condition, identify the relationship of the respiratory injury to tetrahydrocannabinol-containing products, and stem the rise in new cases. In this report, we present a comprehensive review of the clinical characteristics and features of patients with e-cigarette or vaping-associated lung injury and guidelines for patient care and management to inform and navigate clinicians who may encounter these patients in their clinical practice.
- Published
- 2020